[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Active Pharmaceutical Ingredients Market Report 2018

March 2018 | 117 pages | ID: U7E09A65586QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Active Pharmaceutical Ingredients market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Active Pharmaceutical Ingredients in these regions, from 2013 to 2025 (forecast).
United States Active Pharmaceutical Ingredients market competition by top manufacturers/players, with Active Pharmaceutical Ingredients sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Teva
  • Mylan
  • DSM
  • Aurobindo Pharma
  • Aspen
  • Novartis
  • BASF
  • Pfizer
  • Huahai Pharmaceutical
  • Hisun Pharmaceutical
  • Sun Pharmaceutical Industries
  • Zhejiang Medicine
  • Dr. Reddy's Laboratories
  • Zhejiang NHU
  • Bayer
  • NCPC
  • AbbVie
  • Shandong Xinhua Pharmaceutical
  • Northeast Pharm
  • Harbin Pharmaceutical
  • LKPC
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • Synthetic APIs
  • Biotech APIs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • CNS
  • Cardiovascular
  • Genitourinary/Hormonal Drugs
  • Respiratory
  • Rheumatology
  • Diabetes
  • Oncology
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Active Pharmaceutical Ingredients Market Report 2018

1 ACTIVE PHARMACEUTICAL INGREDIENTS OVERVIEW

1.1 Product Overview and Scope of Active Pharmaceutical Ingredients
1.2 Classification of Active Pharmaceutical Ingredients by Product Category
  1.2.1 United States Active Pharmaceutical Ingredients Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Active Pharmaceutical Ingredients Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Synthetic APIs
  1.2.4 Biotech APIs
1.3 United States Active Pharmaceutical Ingredients Market by Application/End Users
  1.3.1 United States Active Pharmaceutical Ingredients Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 CNS
  1.3.3 Cardiovascular
  1.3.4 Genitourinary/Hormonal Drugs
  1.3.5 Respiratory
  1.3.6 Rheumatology
  1.3.7 Diabetes
  1.3.8 Oncology
  1.3.9 Others
1.4 United States Active Pharmaceutical Ingredients Market by Region
  1.4.1 United States Active Pharmaceutical Ingredients Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Active Pharmaceutical Ingredients Status and Prospect (2013-2025)
  1.4.3 Southwest Active Pharmaceutical Ingredients Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Active Pharmaceutical Ingredients Status and Prospect (2013-2025)
  1.4.5 New England Active Pharmaceutical Ingredients Status and Prospect (2013-2025)
  1.4.6 The South Active Pharmaceutical Ingredients Status and Prospect (2013-2025)
  1.4.7 The Midwest Active Pharmaceutical Ingredients Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Active Pharmaceutical Ingredients (2013-2025)
  1.5.1 United States Active Pharmaceutical Ingredients Sales and Growth Rate (2013-2025)
  1.5.2 United States Active Pharmaceutical Ingredients Revenue and Growth Rate (2013-2025)

2 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Active Pharmaceutical Ingredients Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Active Pharmaceutical Ingredients Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Active Pharmaceutical Ingredients Average Price by Players/Suppliers (2013-2018)
2.4 United States Active Pharmaceutical Ingredients Market Competitive Situation and Trends
  2.4.1 United States Active Pharmaceutical Ingredients Market Concentration Rate
  2.4.2 United States Active Pharmaceutical Ingredients Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Active Pharmaceutical Ingredients Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Active Pharmaceutical Ingredients Sales and Market Share by Region (2013-2018)
3.2 United States Active Pharmaceutical Ingredients Revenue and Market Share by Region (2013-2018)
3.3 United States Active Pharmaceutical Ingredients Price by Region (2013-2018)

4 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Active Pharmaceutical Ingredients Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Active Pharmaceutical Ingredients Revenue and Market Share by Type (2013-2018)
4.3 United States Active Pharmaceutical Ingredients Price by Type (2013-2018)
4.4 United States Active Pharmaceutical Ingredients Sales Growth Rate by Type (2013-2018)

5 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Active Pharmaceutical Ingredients Sales and Market Share by Application (2013-2018)
5.2 United States Active Pharmaceutical Ingredients Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Teva
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Active Pharmaceutical Ingredients Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Teva Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Mylan
  6.2.2 Active Pharmaceutical Ingredients Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Mylan Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 DSM
  6.3.2 Active Pharmaceutical Ingredients Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 DSM Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Aurobindo Pharma
  6.4.2 Active Pharmaceutical Ingredients Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Aurobindo Pharma Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Aspen
  6.5.2 Active Pharmaceutical Ingredients Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Aspen Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Novartis
  6.6.2 Active Pharmaceutical Ingredients Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Novartis Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 BASF
  6.7.2 Active Pharmaceutical Ingredients Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 BASF Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Pfizer
  6.8.2 Active Pharmaceutical Ingredients Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Pfizer Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Huahai Pharmaceutical
  6.9.2 Active Pharmaceutical Ingredients Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Huahai Pharmaceutical Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Hisun Pharmaceutical
  6.10.2 Active Pharmaceutical Ingredients Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Hisun Pharmaceutical Active Pharmaceutical Ingredients Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Sun Pharmaceutical Industries
6.12 Zhejiang Medicine
6.13 Dr. Reddy's Laboratories
6.14 Zhejiang NHU
6.15 Bayer
6.16 NCPC
6.17 AbbVie
6.18 Shandong Xinhua Pharmaceutical
6.19 Northeast Pharm
6.20 Harbin Pharmaceutical
6.21 LKPC

7 ACTIVE PHARMACEUTICAL INGREDIENTS MANUFACTURING COST ANALYSIS

7.1 Active Pharmaceutical Ingredients Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Active Pharmaceutical Ingredients

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Active Pharmaceutical Ingredients Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Active Pharmaceutical Ingredients Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ACTIVE PHARMACEUTICAL INGREDIENTS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Active Pharmaceutical Ingredients Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Active Pharmaceutical Ingredients Sales Volume Forecast by Type (2018-2025)
11.3 United States Active Pharmaceutical Ingredients Sales Volume Forecast by Application (2018-2025)
11.4 United States Active Pharmaceutical Ingredients Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Active Pharmaceutical Ingredients
Figure United States Active Pharmaceutical Ingredients Market Size (K Units) by Type (2013-2025)
Figure United States Active Pharmaceutical Ingredients Sales Volume Market Share by Type (Product Category) in 2017
Figure Synthetic APIs Product Picture
Figure Biotech APIs Product Picture
Figure United States Active Pharmaceutical Ingredients Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Active Pharmaceutical Ingredients by Application in 2017
Figure CNS Examples
Table Key Downstream Customer in CNS
Figure Cardiovascular Examples
Table Key Downstream Customer in Cardiovascular
Figure Genitourinary/Hormonal Drugs Examples
Table Key Downstream Customer in Genitourinary/Hormonal Drugs
Figure Respiratory Examples
Table Key Downstream Customer in Respiratory
Figure Rheumatology Examples
Table Key Downstream Customer in Rheumatology
Figure Diabetes Examples
Table Key Downstream Customer in Diabetes
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Active Pharmaceutical Ingredients Market Size (Million USD) by Region (2013-2025)
Figure The West Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Active Pharmaceutical Ingredients Sales (K Units) and Growth Rate (2013-2025)
Figure United States Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Active Pharmaceutical Ingredients Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Active Pharmaceutical Ingredients Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Active Pharmaceutical Ingredients Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Active Pharmaceutical Ingredients Sales Share by Players/Suppliers
Figure 2017 United States Active Pharmaceutical Ingredients Sales Share by Players/Suppliers
Figure United States Active Pharmaceutical Ingredients Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Active Pharmaceutical Ingredients Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Active Pharmaceutical Ingredients Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Active Pharmaceutical Ingredients Revenue Share by Players/Suppliers
Figure 2017 United States Active Pharmaceutical Ingredients Revenue Share by Players/Suppliers
Table United States Market Active Pharmaceutical Ingredients Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Active Pharmaceutical Ingredients Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Active Pharmaceutical Ingredients Market Share of Top 3 Players/Suppliers
Figure United States Active Pharmaceutical Ingredients Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Active Pharmaceutical Ingredients Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Active Pharmaceutical Ingredients Product Category
Table United States Active Pharmaceutical Ingredients Sales (K Units) by Region (2013-2018)
Table United States Active Pharmaceutical Ingredients Sales Share by Region (2013-2018)
Figure United States Active Pharmaceutical Ingredients Sales Share by Region (2013-2018)
Figure United States Active Pharmaceutical Ingredients Sales Market Share by Region in 2017
Table United States Active Pharmaceutical Ingredients Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Active Pharmaceutical Ingredients Revenue Share by Region (2013-2018)
Figure United States Active Pharmaceutical Ingredients Revenue Market Share by Region (2013-2018)
Figure United States Active Pharmaceutical Ingredients Revenue Market Share by Region in 2017
Table United States Active Pharmaceutical Ingredients Price (USD/Unit) by Region (2013-2018)
Table United States Active Pharmaceutical Ingredients Sales (K Units) by Type (2013-2018)
Table United States Active Pharmaceutical Ingredients Sales Share by Type (2013-2018)
Figure United States Active Pharmaceutical Ingredients Sales Share by Type (2013-2018)
Figure United States Active Pharmaceutical Ingredients Sales Market Share by Type in 2017
Table United States Active Pharmaceutical Ingredients Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Active Pharmaceutical Ingredients Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Type (2013-2018)
Figure Revenue Market Share of Active Pharmaceutical Ingredients by Type in 2017
Table United States Active Pharmaceutical Ingredients Price (USD/Unit) by Types (2013-2018)
Figure United States Active Pharmaceutical Ingredients Sales Growth Rate by Type (2013-2018)
Table United States Active Pharmaceutical Ingredients Sales (K Units) by Application (2013-2018)
Table United States Active Pharmaceutical Ingredients Sales Market Share by Application (2013-2018)
Figure United States Active Pharmaceutical Ingredients Sales Market Share by Application (2013-2018)
Figure United States Active Pharmaceutical Ingredients Sales Market Share by Application in 2017
Table United States Active Pharmaceutical Ingredients Sales Growth Rate by Application (2013-2018)
Figure United States Active Pharmaceutical Ingredients Sales Growth Rate by Application (2013-2018)
Table Teva Basic Information List
Table Teva Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Teva Active Pharmaceutical Ingredients Sales Growth Rate (2013-2018)
Figure Teva Active Pharmaceutical Ingredients Sales Market Share in United States (2013-2018)
Figure Teva Active Pharmaceutical Ingredients Revenue Market Share in United States (2013-2018)
Table Mylan Basic Information List
Table Mylan Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Mylan Active Pharmaceutical Ingredients Sales Growth Rate (2013-2018)
Figure Mylan Active Pharmaceutical Ingredients Sales Market Share in United States (2013-2018)
Figure Mylan Active Pharmaceutical Ingredients Revenue Market Share in United States (2013-2018)
Table DSM Basic Information List
Table DSM Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure DSM Active Pharmaceutical Ingredients Sales Growth Rate (2013-2018)
Figure DSM Active Pharmaceutical Ingredients Sales Market Share in United States (2013-2018)
Figure DSM Active Pharmaceutical Ingredients Revenue Market Share in United States (2013-2018)
Table Aurobindo Pharma Basic Information List
Table Aurobindo Pharma Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aurobindo Pharma Active Pharmaceutical Ingredients Sales Growth Rate (2013-2018)
Figure Aurobindo Pharma Active Pharmaceutical Ingredients Sales Market Share in United States (2013-2018)
Figure Aurobindo Pharma Active Pharmaceutical Ingredients Revenue Market Share in United States (2013-2018)
Table Aspen Basic Information List
Table Aspen Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Aspen Active Pharmaceutical Ingredients Sales Growth Rate (2013-2018)
Figure Aspen Active Pharmaceutical Ingredients Sales Market Share in United States (2013-2018)
Figure Aspen Active Pharmaceutical Ingredients Revenue Market Share in United States (2013-2018)
Table Novartis Basic Information List
Table Novartis Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Novartis Active Pharmaceutical Ingredients Sales Growth Rate (2013-2018)
Figure Novartis Active Pharmaceutical Ingredients Sales Market Share in United States (2013-2018)
Figure Novartis Active Pharmaceutical Ingredients Revenue Market Share in United States (2013-2018)
Table BASF Basic Information List
Table BASF Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure BASF Active Pharmaceutical Ingredients Sales Growth Rate (2013-2018)
Figure BASF Active Pharmaceutical Ingredients Sales Market Share in United States (2013-2018)
Figure BASF Active Pharmaceutical Ingredients Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Pfizer Active Pharmaceutical Ingredients Sales Growth Rate (2013-2018)
Figure Pfizer Active Pharmaceutical Ingredients Sales Market Share in United States (2013-2018)
Figure Pfizer Active Pharmaceutical Ingredients Revenue Market Share in United States (2013-2018)
Table Huahai Pharmaceutical Basic Information List
Table Huahai Pharmaceutical Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Huahai Pharmaceutical Active Pharmaceutical Ingredients Sales Growth Rate (2013-2018)
Figure Huahai Pharmaceutical Active Pharmaceutical Ingredients Sales Market Share in United States (2013-2018)
Figure Huahai Pharmaceutical Active Pharmaceutical Ingredients Revenue Market Share in United States (2013-2018)
Table Hisun Pharmaceutical Basic Information List
Table Hisun Pharmaceutical Active Pharmaceutical Ingredients Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Hisun Pharmaceutical Active Pharmaceutical Ingredients Sales Growth Rate (2013-2018)
Figure Hisun Pharmaceutical Active Pharmaceutical Ingredients Sales Market Share in United States (2013-2018)
Figure Hisun Pharmaceutical Active Pharmaceutical Ingredients Revenue Market Share in United States (2013-2018)
Table Sun Pharmaceutical Industries Basic Information List
Table Zhejiang Medicine Basic Information List
Table Dr. Reddy's Laboratories Basic Information List
Table Zhejiang NHU Basic Information List
Table Bayer Basic Information List
Table NCPC Basic Information List
Table AbbVie Basic Information List
Table Shandong Xinhua Pharmaceutical Basic Information List
Table Northeast Pharm Basic Information List
Table Harbin Pharmaceutical Basic Information List
Table LKPC Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Active Pharmaceutical Ingredients
Figure Manufacturing Process Analysis of Active Pharmaceutical Ingredients
Figure Active Pharmaceutical Ingredients Industrial Chain Analysis
Table Raw Materials Sources of Active Pharmaceutical Ingredients Major Players/Suppliers in 2017
Table Major Buyers of Active Pharmaceutical Ingredients
Table Distributors/Traders List
Figure United States Active Pharmaceutical Ingredients Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Active Pharmaceutical Ingredients Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Active Pharmaceutical Ingredients Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Active Pharmaceutical Ingredients Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Active Pharmaceutical Ingredients Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Active Pharmaceutical Ingredients Sales Volume (K Units) Forecast by Type in 2025
Table United States Active Pharmaceutical Ingredients Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Active Pharmaceutical Ingredients Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Active Pharmaceutical Ingredients Sales Volume (K Units) Forecast by Application in 2025
Table United States Active Pharmaceutical Ingredients Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Active Pharmaceutical Ingredients Sales Volume Share Forecast by Region (2018-2025)
Figure United States Active Pharmaceutical Ingredients Sales Volume Share Forecast by Region (2018-2025)
Figure United States Active Pharmaceutical Ingredients Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories